MariMed (OTC: MRMD) is engaged in the design, development, operation, funding and optimization of medical cannabis cultivation and production centers and dispensaries. The MariMed team has developed state of the art and regulatory compliant facilities in multiple states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development and dispensary operations. The company is on the forefront of medical research working to create precision dosing to treat specific conditions. For more information, visit the company’s website at www.MarimedAdvisors.com
About CBDWire
CBDWire (CBDW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3) a full array of social communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, CO
cbdwire.com
212.418.1217 Office
Editor@CBDWire.com
